| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.065 | 0.02 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.03 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.063 | 0.03 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |